Literature DB >> 20346486

Perioperative management of patients undergoing sling surgery: a survey of US urologists.

Mia Swartz1, Sandip Vasavada, Howard Goldman.   

Abstract

OBJECTIVES: Anti-incontinence procedures are common. However, perioperative practices are variable and no consensus guidelines exist. Our primary objective was to describe contemporary management of patients undergoing routine sling surgery alone.
METHODS: A 15-item survey was designed to assess physician characteristics and perioperative management among urologists. Following institutional review board approval, the American Urological Association (AUA) administered the survey to 7433 urologists followed by an e-mail reminder 7 days later. Responders were excluded if they never performed sling surgery or were still in training.
RESULTS: There were 960 (12.9%) urologists who responded, and 618 surveys met inclusion criteria. Sixty-nine (11.2%) were fellowship trained and most (53.2%) performed 5-25 slings annually, with the transobturator approach most commonly used (53.6%). The majority (69.1%) discharged patients the day of surgery. The most common rationale for admitting urologists is to facilitate voiding trials (42.4%). Hospital admission is highly correlated using retropubic slings (P < .001). Discharge with a catheter is routine for 157 (25.4%) urologists. A postvoid residual is most frequently used for voiding trials (49.8%). Most urologists (54.5%) prescribe antibiotics for longer than 5 days and cited reasons including prevention of sling infections/extrusions/erosions (54.5%) and urinary tract infections (18.1%). There was no correlation between management and fellowship training. Urologists >50 years used postoperative antibiotics more often (P < .01).
CONCLUSIONS: This survey confirms the variance of management after sling surgery. Although the AUA recommends </=24 hours of postoperative antibiotics after slings, extended courses continue to be prescribed. This variability in practice patterns underscores the need for consensus guidelines regarding perioperative management of these patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20346486     DOI: 10.1016/j.urology.2009.11.084

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  One normal void and residual following MUS surgery is all that is necessary in most patients.

Authors:  Paul Ballard; Sami Shawer; Colette Anderson; Aethele Khunda
Journal:  Int Urogynecol J       Date:  2017-09-04       Impact factor: 2.894

2.  FAST discharge without catheterization after sling therapy.

Authors:  Jason Kim; Kathleen C Kobashi
Journal:  Nat Rev Urol       Date:  2011-04       Impact factor: 14.432

3.  A randomized controlled trial comparing two voiding trials after midurethral sling with or without colporrhaphy.

Authors:  Kathryn S Williams; Marjorie L Pilkinton; Dara F Shalom; Harvey A Winkler
Journal:  Int Urogynecol J       Date:  2018-10-06       Impact factor: 2.894

4.  Argus T® versus Advance® Sling for postprostatectomy urinary incontinence: A randomized clinical trial.

Authors:  Joao Paulo Cunha Lima; Antonio Carlos Lima Pompeo; Carlos Alberto Bezerra
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

5.  The Urological Society of India survey on urinary incontinence practice patterns among urologists.

Authors:  Sanjay Sinha; Shirish Yande; Anita Patel; Ajit Vaze; Kalyan Sarkar; Shailesh Raina; Mayank Mohan Agarwal; Pawan Vasudeva; Nikhil Khattar; Vijay Kumar Sarma Madduri; Nagendranath Mishra; Amita Jain; Manu Gupta
Journal:  Indian J Urol       Date:  2018 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.